Samuël Arends

Samuël Arends is a Researcher in the Department of Neurology at Erasmus University Medical Center, Rotterdam, Netherlands, affiliated with the Erasmus School of Medicine. His work primarily focuses on neurological disorders with particular emphasis on Guillain-Barré Syndrome (GBS) and related conditions.

His research interests center around Guillain-Barré Syndrome, electrodiagnosis, infectious triggers of neurological disorders, respiratory complications in neurological patients, and cognitive disorders. Dr. Arends has made significant contributions to understanding the clinical characteristics, diagnostic approaches, and management strategies for GBS patients.

Analysis of his publication record reveals a strong focus on Guillain-Barré Syndrome research, with multiple studies examining electrodiagnostic subtyping, CSF findings, respiratory complications, and preceding infections. His work often involves large international collaborations, particularly through the International Guillain-Barré Outcome Study (IGOS) Consortium. The research demonstrates an interdisciplinary approach combining neurology, immunology, and critical care medicine to improve diagnosis and treatment of neurological conditions.

Dr. Arends is actively involved in the International Guillain-Barré Outcome Study (IGOS) Consortium, a major collaborative effort studying GBS across multiple international centers. His work contributes to developing clinical tools like the Modified Erasmus GBS Respiratory Insufficiency Score, which helps predict mechanical ventilation needs in GBS patients.